Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells

被引:57
作者
Kleine-Lowinski, K
Rheinwald, JG
Fichorova, RN
Anderson, DJ
Basile, J
Münger, K
Daly, CM
Rösl, F
Rollins, BJ
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA
[4] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
关键词
cervical cancer; human papillomavirus; E6; E7; chemokine; monocyte chemoattractant protein-I;
D O I
10.1002/ijc.11411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infection of cervical keratinocytes by high-risk HPV is involved in the etiology of cervical carcinoma. Since viral products are immunogenic, development of cancer may require suppression of immune responses directed against infected epithelial cells. Many markers of host immune effector responses decrease as cervical intraepithelial neoplasia progresses. Among these is epithelial cell expression of the chemokine MCP-I, though the mechanism for its suppression is unclear. Here, we show that the E6 and E7 viral oncogenes from high-risk HPV, individually and together, suppress MCP-I expression in primary epithelial cells derived from the female genital tract. This is not a consequence of global suppression of chemokine expression since other chemokines, including IP-10, IL-8 and RANTES, were less affected. Furthermore, 4 of 6 HPV-positive cervical carcinoma cell lines did not express MCP-I. Our data indicate that suppression of MCP-I expression is part of the program of high-risk HPV E6/E7-induced transformation of primary epithelial cells. These observations are consistent with a model in which MCP-I expression by infected keratinocytes, which would stimulate an immune attack on HPV-transformed cells, is suppressed for invasive cervical cancer to appear. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 33 条
[1]   Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis [J].
Aguilar-Lemarroy, A ;
Gariglio, P ;
Whitaker, NJ ;
Eichhorst, ST ;
zur Hausen, H ;
Krammer, PH ;
Rösl, F .
ONCOGENE, 2002, 21 (02) :165-175
[2]   ANTIGEN PRESENTATION BY KERATINOCYTES INDUCES TOLERANCE IN HUMAN T-CELLS [J].
BAL, V ;
MCINDOE, A ;
DENTON, G ;
HUDSON, D ;
LOMBARDI, G ;
LAMB, J ;
LECHLER, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) :1893-1897
[3]  
BARKER JNWN, 1991, J IMMUNOL, V146, P1192
[4]   HUMAN PAPILLOMAVIRUS TYPE-16 NUCLEOPROTEIN-E7 IS A TUMOR REJECTION ANTIGEN [J].
CHEN, LP ;
THOMAS, EK ;
HU, SL ;
HELLSTROM, I ;
HELLSTROM, KE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (01) :110-114
[5]  
CROOK T, 1991, ONCOGENE, V6, P873
[6]   ROLE OF KERATINOCYTES IN HUMAN RECURRENT HERPETIC LESIONS - ABILITY TO PRESENT HERPES-SIMPLEX VIRUS-ANTIGEN AND ACT AS TARGETS FOR LYMPHOCYTE-T CYTO-TOXICITY INVITRO [J].
CUNNINGHAM, AL ;
NOBLE, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02) :490-496
[7]   Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics [J].
Dickson, MA ;
Hahn, WC ;
Ino, Y ;
Ronfard, V ;
Wu, JY ;
Weinberg, RA ;
Louis, DN ;
Li, FP ;
Rheinwald, JG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (04) :1436-1447
[8]   Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins [J].
Fichorova, RN ;
Rheinwald, JG ;
Anderson, DJ .
BIOLOGY OF REPRODUCTION, 1997, 57 (04) :847-855
[9]   Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells:: The role of the chromatin structure and AP-1 composition [J].
Finzer, P ;
Soto, U ;
Delius, H ;
Patzelt, A ;
Coy, JF ;
Poustka, A ;
zur Hausen, H ;
Rösl, F .
ONCOGENE, 2000, 19 (29) :3235-3244
[10]   Immunology of papillomavirus infection [J].
Frazer, IH .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :484-491